Putnam Investments LLC Seres Therapeutics, Inc. Transaction History

Putnam Investments LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $525,911 - $1.48 Million	-194,782 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $91,444 - $128,312	-14,515 Reduced 6.94%	194,782 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $1.26 Million - $2.39 Million	209,297 New	209,297 $1.74 Million

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.